Aberrant fetal growth remains a leading cause of perinatal morbidity and mortality and is
associated with a risk of developing non-communicable diseases later in life. We performed …

The use of functional nutrients has been proposed to reduce the occurrence of intrauterine
growth retardation in animals at birth in several mammalian species. The objective of this …

Maternal dietary protein supplementation to improve fetal growth has been considered as an
option to prevent or treat intrauterine growth restriction. However, in contrast to balanced …

Maternal nutrition during gestation, especially dietary protein intake, is a key determinant in
embryonic survival, growth, and development. Low maternal dietary protein intake can …

Background & aims Previous research established that the availability of l-arginine affects
placental vascular development and fetal growth. However, practical details associated with …

By serving as a precursor for the synthesis of nitric oxide, polyamines, and other molecules
with biological importance, arginine plays a key role in pregnancy and fetal development …

The available data support the hypothesis that L-arginine or L-citrulline supplementation
would be suitable for implementation in resource-constrained settings and will enhance …

Intrauterine growth restriction (IUGR) is one of the most common concerns in human
obstetrics and domestic animal production. It is usually caused by placental insufficiency …

Embryonic loss and intrauterine growth restriction (IUGR) are significant problems in
humans and other animals. Results from studies involving pigs and sheep have indicated …

The use of functional amino acids during pregnancy has been linked to improved
reproduction in mammals. In this context, arginine is a precursor in the synthesis of …